Search research articles
Contact Us
Filters
Showing results (271-280 of 315) with videos related to
Page
of 32
Sort By:
Current Medical Science
|
August 31, 2020
Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca<sup>2+</sup>-STIM1/Orai1 Signaling
Yi-da Hu, Chao-Liang Tang, Jia-Zhen Jiang, et al.
Molecular Medicine Reports
|
April 29, 2016
Critical role of oncogenic KRAS in pancreatic cancer (Review)
Jiang Liu, Shunrong Ji, Chen Liang, et al.
Human Vaccines & Immunotherapeutics
|
November 5, 2025
Economic burden of invasive pneumococcal disease in hospitalized children in Zhejiang Province, China: A multicenter hospital-based study conducted from 2014-2024
Zhao-Jun Lu, Jin-Si Zhou, Yan-Yan Zhu, et al.
Gut
|
August 4, 2023
CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma
Xiaomeng Liu, Rong Tang, Jin Xu, et al.
Cancer Research
|
September 17, 2024
CircRREB1 Mediates Metabolic Reprogramming and Stemness Maintenance to Facilitate Pancreatic Ductal Adenocarcinoma Progression
Zeyin Rong, Jin Xu, Jianhui Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 13, 2026
Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer
Chen Chen, Dingru Li, Yingna Liao, et al.
Cell Death & Disease
|
February 25, 2018
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
Jinfeng Xiang, Qiangsheng Hu, Yi Qin, et al.
Molecular Cancer
|
August 9, 2014
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
Wantong Yao, Shunrong Ji, Yi Qin, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 2025
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial
Ying Cheng, Panpan Zhang, Ming Lu, et al.
Gut
|
November 5, 2024
TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality
Mingming Xiao, Rong Tang, Haoqi Pan, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 315) with videos related to
Sort By:
Page
of 32
Current Medical Science
|
August 31, 2020
Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca<sup>2+</sup>-STIM1/Orai1 Signaling
Yi-da Hu, Chao-Liang Tang, Jia-Zhen Jiang, et al.
Molecular Medicine Reports
|
April 29, 2016
Critical role of oncogenic KRAS in pancreatic cancer (Review)
Jiang Liu, Shunrong Ji, Chen Liang, et al.
Human Vaccines & Immunotherapeutics
|
November 5, 2025
Economic burden of invasive pneumococcal disease in hospitalized children in Zhejiang Province, China: A multicenter hospital-based study conducted from 2014-2024
Zhao-Jun Lu, Jin-Si Zhou, Yan-Yan Zhu, et al.
Gut
|
August 4, 2023
CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma
Xiaomeng Liu, Rong Tang, Jin Xu, et al.
Cancer Research
|
September 17, 2024
CircRREB1 Mediates Metabolic Reprogramming and Stemness Maintenance to Facilitate Pancreatic Ductal Adenocarcinoma Progression
Zeyin Rong, Jin Xu, Jianhui Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 13, 2026
Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer
Chen Chen, Dingru Li, Yingna Liao, et al.
Cell Death & Disease
|
February 25, 2018
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
Jinfeng Xiang, Qiangsheng Hu, Yi Qin, et al.
Molecular Cancer
|
August 9, 2014
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
Wantong Yao, Shunrong Ji, Yi Qin, et al.
Cancer Immunology, Immunotherapy : CII
|
February 1, 2025
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial
Ying Cheng, Panpan Zhang, Ming Lu, et al.
Gut
|
November 5, 2024
TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality
Mingming Xiao, Rong Tang, Haoqi Pan, et al.
Page
of 32